Telomere and telomerase in chronic liver disease and hepatocarcinoma. - Wikidata - awgldk - TriplyDB

Telomere and telomerase in chronic liver disease and hepatocarcinoma.

Telomere and telomerase in chronic liver disease and hepatocarcinoma.

http://www.wikidata.org/entity/Q38216014

about

Adaptive immunity in the liver Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinoma.Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma.Telomere Length in Peripheral Blood Leukocytes Is Associated with Severity of Biliary Atresia The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma.Genetic and epigenetic trends in telomere research: a novel way in immunoepigenetics.PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma.The immune system in hepatocellular carcinoma and potential new immunotherapeutic strategies.Telomere shortening as genetic risk factor of liver cirrhosis.Apoptosis in the aging liver.Activated carbon N-acetylcysteine microcapsule protects against nonalcoholic fatty liver disease in young rats via activating telomerase and inhibiting apoptosis.

P2860

Q26753195-54754807-DD42-41B0-AB5E-C1C809E9B852 Q33688632-EECCD980-39A8-4AF5-A62A-97A0336E71D2 Q33706203-1B527228-C274-46BF-929E-7BCE048AC9A4 Q35731128-49EE8BB5-6CF6-4A88-BA01-8C99E0C65F08 Q37194184-0F82828A-1E91-4249-B422-C18F298A2EC4 Q37688043-39E01109-13CC-478E-916F-98B5294166E9 Q38550343-614F9AFC-99B2-409C-8CB9-06A4FE1FA341 Q39377876-51CDE034-E0E8-4367-A7CB-E070E38C0D1B Q39535683-13FAB181-0CEB-48A4-B8B9-8BC6CCFB7B76 Q43103562-656FE580-D98A-42CC-883C-0451CC221895 Q47104199-3605E677-723E-49CD-AF86-688AE2766D84 Q49614371-D4CCC661-E591-44BC-BC92-B46E7D0C8329

P2860

Telomere and telomerase in chronic liver disease and hepatocarcinoma.

http://www.wikidata.org/entity/Q38216014

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Telomere and telomerase in chronic liver disease and hepatocarcinoma.

@en

type

label

Telomere and telomerase in chronic liver disease and hepatocarcinoma.

@en

prefLabel

Telomere and telomerase in chronic liver disease and hepatocarcinoma.

@en

P1433

Q38216014-6D764612-8324-4B01-8319-2DC5CF1788F6

P1476

Q38216014-AF904C1D-5889-424D-BCE8-B064BFF776B0

P2093

Q38216014-5A46CFD2-D3BF-4348-B582-43EA5E5C930E

P2860

Q38216014-017A23C4-C15D-4191-8797-A752FD172D48

Q38216014-05571C11-14BE-4A9D-B33D-DD2E61E452E5

Q38216014-0C5D69A6-AB9B-4727-8582-4BE8FBF8F8E8

Q38216014-0D85D8E0-3FC9-44A9-B5AA-046502565C98

Q38216014-1124210D-5C10-41BA-9D4E-1D8CD6B016D7

Q38216014-1F88185F-F5ED-468E-89C6-9EBAF43A80EE

Q38216014-2266E386-94C7-4DBC-B5C0-1AEB8A572AD7

Q38216014-26DB05A4-B188-4DC3-B437-7A3E8FF3AB69

Q38216014-36D2DFA8-C1CF-413F-8747-537DCBE78EBD

Q38216014-386E9EBA-C447-41FE-BFFA-380CB2F21DB5

P304

Q38216014-D2246337-EBBA-42B5-A6AA-F587624634D4

P31

Q38216014-B4090547-6FBF-4B4D-97A9-D824369C0A51

P356

Q38216014-19264C7E-2D12-4819-BC09-EBDEF2DA49E2

P407

Q38216014-15A72965-6CF5-4BFE-B736-D794918B09A4

P433

Q38216014-9981F37D-7905-476B-92B3-BF60FCA07A0C

P478

Q38216014-F06F6582-1B75-4E38-BB11-76945FA08984

P50

Q38216014-DDC5D3EF-9350-4FBA-B1C4-F3EC840A5C7E

P577

Q38216014-69D82DB2-D30E-498B-9D34-C6B1D4B74C7E

P5875

Q38216014-AC06903E-5E95-4D0A-890E-37E24106ACBD

P698

Q38216014-ACCA2312-FC63-43F5-85C5-704CEAB592DB

P932

Q38216014-28E47048-D399-40FC-8133-0322749AF934

P356

WJG.V20.I20.6287

P1433

World Journal of Gastroenterology

P1476

Telomere and telomerase in chronic liver disease and hepatocarcinoma

@en

P2093

Claudia Anzivino

http://www.w3.org/2001/XMLSchema#string

P2860

A telomerase component is defective in the human disease dyskeratosis congenita

TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes

Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita

The telomere syndromes

Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis

Telomerase and idiopathic pulmonary fibrosis

Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1

Creation of human tumour cells with defined genetic elements

Identification of a specific telomere terminal transferase activity in Tetrahymena extracts

Switching and signaling at the telomere

P304

6287-6292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V20.I20.6287

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262787055

http://www.w3.org/2001/XMLSchema#string

P698

24876749

http://www.w3.org/2001/XMLSchema#string

P932

4033466

http://www.w3.org/2001/XMLSchema#string